|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000080326 |
| 005 |
20130115093000.0 |
| 008 |
120210s2012 ne eng |
| 020 |
|
|
|a 9780123919113
|
| 050 |
0 |
0 |
|a R853.C55
|b B76 2012
|
| 060 |
0 |
0 |
|a QV 771
|b B863c 2012
|
| 090 |
0 |
0 |
|a QV 771
|b B863c 2012
|
| 100 |
1 |
|
|a Brody, Tom ,
|e author
|
| 245 |
1 |
0 |
|a Clinical trials :
|b study design, endpoints and biomarkers, drug safety, FDA and ICH guidelines
|c Tom Brody
|
| 260 |
|
|
|a Amsterdam
|a Boston :
|b Elsevier/AP ,
|c 2012
|
| 300 |
|
|
|a xxxiii, 638 p. :
|b ill. ;
|c 24 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 650 |
|
0 |
|a Clinical trials
|
| 650 |
|
0 |
|a Drug approval
|
| 650 |
|
2 |
|a Clinical Trials as Topic
|
| 650 |
2 |
2 |
|a Clinical Trials Data Monitoring Committees
|
| 650 |
2 |
2 |
|a Drug Approval
|
| 650 |
2 |
2 |
|a Research Design
|
| 999 |
|
|
|a 1000149356
|b Book
|c OPEN SHELF (30 DAYS)
|e Medical Campus
|